Oncologists Accepting Humana in MassachusettsPage 3

Haeseong Park, MD

Medical Oncology

Oncology

Lakshmi Nayak, M.D.

Director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute in Boston. She is an Associate Professor of Neurology at Harvard Medical School. She r; Director of the Center for Central Nervous System (CNS) Lymphoma

Oncology

William Hahn, MD PHD

Professor of Medicine in the Department of Medical Oncology at Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Ins; Chief Operating and Transformation Officer at the Dana-Farber Cancer Institute.

Oncology

Caroline Block, MD

Chief of Hematology and Medical Oncology, Medical Director of the Breast Clinic, Director of Oncology Clinical Research and Director of the Anticoagulation; Director

Oncology

Rinath Jeselsohn, M.D.

Researcher Physician, Director for ER+ Translational Discovery Research, Assistant Professor of Medicine at Harvard Medical School

Oncology

James Decaprio, MD

Professor of Medicine, Harvard Medical School

Oncology

Elizabeth Henske, M.D.

Director, Center for LAM Research and Clinical Care; Professor of Medicine, Harvard Medical School

Oncology

Praful Ravi, MB BCHIR

Assistant Professor of Medicine, Harvard Medical School; Director of GU Theranostics, Dana-Farber Cancer Institute

Oncology

Michael Cassidy, M.D.

Oncology

Thanh Barbie, MD

Assistant Professor of Surgery, Harvard Medical School

Oncology

Candace Haddox, M.D.

Clinical Investigator, Sarcoma Center

Oncology

Mahasweta Gooptu, M.D.

Assistant Professor of Medicine, Harvard Medical School

Oncology

Taylor Ortiz, MD

Director, Dana-Farber – Merrimack Valley

Oncology

Martha Wadleigh, MD

Director, Inpatient Oncology; Assistant Professor of Medicine, Harvard Medical School

Oncology

George Molina, MD, MPH

Oncology

Rochelle Scheib, MD

Professor of Medicine, Harvard Medical School

Oncology

Rizwan Haq, MD, PHD

Assistant Professor, Harvard Medical School

Oncology

Ting Bao, M.D.

Director of the Zakim Center for Integrative Therapies and Healthy Living at the Dana-Farber Cancer Institute. She was a joint faculty member at Memoria

Oncology

Amy Bregar, MD

Assistant Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Oncology

David Jackman, M.D.

Director for Clinical Pathways and New Business Initiatives. His research interests include targeted therapies in lung cancer and mesothelioma, and canc; Senior Physician

Oncology